Brief: Sedana Medical Q3 EBITDA at SEK -12.6 Million
26/10/2023 06:17
Oct 26 (Reuters) - Sedana Medical Q3 sales SEK 34.3 million. * Q3 net income SEK -6.8 million * Q3 EBIT margin -53% * Q3 EBITDA SEK -12.6 million * Q3 cash flow from operating activities SEK -3.9 million * Q3 adjusted EPS SEK -0.07
Recent news on Sedana Medical AB (publ)
See all newsSweden's Sedana Medical Q3 sales rise as growth returns
Brief: Sedana Medical Announces PDUFA Target Action Date
Brief: Sedana Medical Announces FDA Acceptance For Review Of Its New Drug Application In U.S.
Sweden's Sedana Medical Q2 sales flat, EBITDA loss narrows
Brief: Sedana Medical Q2 EBITDA Loss Narrows To SEK 1.9 Mln